Suppr超能文献

阐明癌症起始细胞(CICs)在肿瘤进展中的作用:多器官检查。

Spelling Out CICs: A Multi-Organ Examination of the Contributions of Cancer Initiating Cells' Role in Tumor Progression.

机构信息

Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, 303 East Superior Street, Chicago, IL, 60611, USA.

Northwestern University, Evanston, IL, 60208, USA.

出版信息

Stem Cell Rev Rep. 2022 Jan;18(1):228-240. doi: 10.1007/s12015-021-10195-x. Epub 2021 Jul 9.

Abstract

Tumor invasion and metastasis remain the leading causes of mortality for patients with cancer despite current treatment strategies. In some cancer types, recurrence is considered inevitable due to the lack of effective anti-metastatic therapies. Recent studies across many cancer types demonstrate a close relationship between cancer-initiating cells (CICs) and metastasis, as well as general cancer progression. First, this review describes CICs' contribution to cancer progression. Then we discuss our recent understanding of mechanisms through which CICs promote tumor invasion and metastasis by examining the role of CICs in each stage. Finally, we examine the current understanding of CICs' contribution to therapeutic resistance and recent developments in CIC-targeting drugs. We believe this understanding is key to advancing anti-CIC clinical therapeutics.

摘要

尽管目前有治疗策略,肿瘤侵袭和转移仍然是癌症患者死亡的主要原因。在某些癌症类型中,由于缺乏有效的抗转移治疗,复发被认为是不可避免的。最近在许多癌症类型中的研究表明,癌症起始细胞(CICs)与转移以及一般癌症进展之间存在密切关系。首先,本综述描述了 CICs 对癌症进展的贡献。然后,我们通过研究 CICs 在每个阶段的作用,讨论了我们对 CICs 促进肿瘤侵袭和转移机制的最新理解。最后,我们研究了目前对 CICs 对治疗耐药性的贡献的理解以及针对 CIC 的药物的最新进展。我们相信,这种理解是推进抗 CIC 临床治疗的关键。

相似文献

1
Spelling Out CICs: A Multi-Organ Examination of the Contributions of Cancer Initiating Cells' Role in Tumor Progression.
Stem Cell Rev Rep. 2022 Jan;18(1):228-240. doi: 10.1007/s12015-021-10195-x. Epub 2021 Jul 9.
2
Differential remodeling of extracellular matrices by breast cancer initiating cells.
J Biophotonics. 2015 Oct;8(10):804-15. doi: 10.1002/jbio.201400079. Epub 2015 Jan 19.
3
Targeting the cancer initiating cell: the ultimate target for cancer therapy.
Curr Pharm Des. 2012;18(13):1784-95. doi: 10.2174/138161212799859701.
4
Possible role of mural cell-covered mature blood vessels in inducing drug resistance in cancer-initiating cells.
Am J Pathol. 2013 May;182(5):1790-9. doi: 10.1016/j.ajpath.2013.01.019. Epub 2013 Mar 7.
5
Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells.
BMC Cancer. 2018 Apr 26;18(1):469. doi: 10.1186/s12885-018-4389-3.
6
Identification and functional analysis of variants of a cancer/testis antigen LEMD1 in colorectal cancer stem-like cells.
Biochem Biophys Res Commun. 2017 Apr 8;485(3):651-657. doi: 10.1016/j.bbrc.2017.02.081. Epub 2017 Feb 20.
7
Lunasin is a novel therapeutic agent for targeting melanoma cancer stem cells.
Oncotarget. 2016 Dec 20;7(51):84128-84141. doi: 10.18632/oncotarget.11554.
8
Targeting the cancer initiating cell: the Achilles' heel of cancer.
Adv Enzyme Regul. 2011;51(1):152-62. doi: 10.1016/j.advenzreg.2010.09.002. Epub 2010 Oct 28.
10
Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy.
Immunol Invest. 2017 Apr;46(3):221-238. doi: 10.1080/08820139.2017.1280051. Epub 2017 Mar 13.

引用本文的文献

1
Autophagy Regulation on Cancer Stem Cell Maintenance, Metastasis, and Therapy Resistance.
Cancers (Basel). 2022 Jan 13;14(2):381. doi: 10.3390/cancers14020381.

本文引用的文献

1
Next-generation stem cells - ushering in a new era of cell-based therapies.
Nat Rev Drug Discov. 2020 Jul;19(7):463-479. doi: 10.1038/s41573-020-0064-x. Epub 2020 Apr 6.
2
Unique properties of a subset of human pluripotent stem cells with high capacity for self-renewal.
Nat Commun. 2020 May 15;11(1):2420. doi: 10.1038/s41467-020-16214-8.
4
LGR5 marks targetable tumor-initiating cells in mouse liver cancer.
Nat Commun. 2020 Apr 23;11(1):1961. doi: 10.1038/s41467-020-15846-0.
5
Targeting cancer stem cell pathways for cancer therapy.
Signal Transduct Target Ther. 2020 Feb 7;5(1):8. doi: 10.1038/s41392-020-0110-5.
6
Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex.
Exp Mol Med. 2020 Feb;52(2):183-191. doi: 10.1038/s12276-020-0380-6. Epub 2020 Feb 10.
7
Asymmetric Inheritance of Cell Fate Determinants: Focus on RNA.
Noncoding RNA. 2019 May 9;5(2):38. doi: 10.3390/ncrna5020038.
9
Stem cells: past, present, and future.
Stem Cell Res Ther. 2019 Feb 26;10(1):68. doi: 10.1186/s13287-019-1165-5.
10
Stem cell fate in cancer growth, progression and therapy resistance.
Nat Rev Cancer. 2018 Nov;18(11):669-680. doi: 10.1038/s41568-018-0056-x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验